These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26901405)

  • 1. Neuroprotective Effect of a DJ-1 Based Peptide in a Toxin Induced Mouse Model of Multiple System Atrophy.
    Glat MJ; Ben-Zur T; Barhum Y; Offen D
    PLoS One; 2016; 11(2):e0148170. PubMed ID: 26901405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism.
    Park HJ; Bang G; Lee BR; Kim HO; Lee PH
    Cell Transplant; 2011; 20(6):827-35. PubMed ID: 21054946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rasagiline is neuroprotective in a transgenic model of multiple system atrophy.
    Stefanova N; Poewe W; Wenning GK
    Exp Neurol; 2008 Apr; 210(2):421-7. PubMed ID: 18222424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.
    Kaindlstorfer C; Sommer P; Georgievska B; Mather RJ; Kugler AR; Poewe W; Wenning GK; Stefanova N
    Neurotox Res; 2015 Oct; 28(3):185-94. PubMed ID: 26194617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards neurotransplantation in multiple system atrophy: clinical rationale, pathophysiological basis, and preliminary experimental evidence.
    Wenning GK; Tison F; Scherfler C; Puschban Z; Waldner R; Granata R; Ghorayeb I; Poewe W
    Cell Transplant; 2000; 9(2):279-88. PubMed ID: 10811400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo models of multiple system atrophy.
    Fernagut PO; Ghorayeb I; Diguet E; Tison F
    Mov Disord; 2005 Aug; 20 Suppl 12():S57-63. PubMed ID: 16092092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy).
    Scherfler C; Sather T; Diguet E; Stefanova N; Puschban Z; Tison F; Poewe W; Wenning GK
    J Neural Transm (Vienna); 2005 Aug; 112(8):1025-33. PubMed ID: 15583958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy.
    Ubhi K; Lee PH; Adame A; Inglis C; Mante M; Rockenstein E; Stefanova N; Wenning GK; Masliah E
    J Neurosci Res; 2009 Sep; 87(12):2728-39. PubMed ID: 19405128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
    Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
    Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of multiple system atrophy.
    Fernagut PO; Tison F
    Neuroscience; 2012 Jun; 211():77-82. PubMed ID: 21963351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy.
    Ubhi K; Rockenstein E; Mante M; Inglis C; Adame A; Patrick C; Masliah E
    Neuroreport; 2010 Apr; 21(6):457-62. PubMed ID: 20224454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. URB597 reduces biochemical, behavioral and morphological alterations in two neurotoxic models in rats.
    Maya-López M; Ruiz-Contreras HA; de Jesús Negrete-Ruíz M; Martínez-Sánchez JE; Benítez-Valenzuela J; Colín-González AL; Villeda-Hernández J; Sánchez-Chapul L; Parra-Cid C; Rangel-López E; Santamaría A
    Biomed Pharmacother; 2017 Apr; 88():745-753. PubMed ID: 28157650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy.
    Glat MJ; Stefanova N; Wenning GK; Offen D
    J Neural Transm (Vienna); 2020 Feb; 127(2):205-212. PubMed ID: 32065333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple system atrophy: an update.
    Wenning GK; Geser F; Stampfer-Kountchev M; Tison F
    Mov Disord; 2003 Sep; 18 Suppl 6():S34-42. PubMed ID: 14502654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.
    Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H
    Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DJ-1 based peptide, ND-13, promote functional recovery in mouse model of focal ischemic injury.
    Molcho L; Ben-Zur T; Barhum Y; Offen D
    PLoS One; 2018; 13(2):e0192954. PubMed ID: 29489843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural transplantation in animal models of multiple system atrophy: a review.
    Wenning GK; Granata R; Puschban Z; Scherfler C; Poewe W
    J Neural Transm Suppl; 1999; 55():103-13. PubMed ID: 10335497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is multiple system atrophy with cerebellar ataxia (MSA-C) like spinocerebellar ataxia and multiple system atrophy with parkinsonism (MSA-P) like Parkinson's disease? - A saccade study on pathophysiology.
    Terao Y; Fukuda H; Tokushige S; Inomata-Terada S; Yugeta A; Hamada M; Ichikawa Y; Hanajima R; Ugawa Y
    Clin Neurophysiol; 2016 Feb; 127(2):1491-1502. PubMed ID: 26350408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
    Ghorayeb I; Fernagut PO; Aubert I; Bezard E; Poewe W; Wenning GK; Tison F
    Mov Disord; 2000 May; 15(3):531-6. PubMed ID: 10830420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.